0000358654
Donate

Reimbursement status:
Full reimbursement

Cancer: Multiple myeloma and plasma cell neoplasms

Indication:

Dexamethasone is indicated in adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products.

Reimbursement information:

EPAR/SmPC

Drug programme

Details

ATC category :
H02AB
H02AB Glucocorticoids
EMA approval status :
Approved
EMA approval date :
2016-03-16
EMA conditional? :
No
EMA orphan? :
Yes
EMA biological? :
No